Laparoscopic Total Gastrectomy for Remnant Gastric Cancer: A Single-institution Experience and Systematic Literature Review.


Journal

In vivo (Athens, Greece)
ISSN: 1791-7549
Titre abrégé: In Vivo
Pays: Greece
ID NLM: 8806809

Informations de publication

Date de publication:
Historique:
received: 06 04 2020
revised: 20 04 2020
accepted: 21 04 2020
entrez: 2 7 2020
pubmed: 2 7 2020
medline: 22 6 2021
Statut: ppublish

Résumé

The safety and efficacy of laparoscopic total gastrectomy (LTG) for remnant gastric cancer (RGC) remains unclear. The purpose of this study was to compare the clinical outcomes of LTG with open total gastrectomy (OTG) for RGC. Twenty-two patients who underwent total gastrectomy for RGC were enrolled in this study. LTG was carried out in seven patients, and OTG was performed in the remaining 15 patients. The mean operation time in the LTG group was longer than that in the OTG group. The estimated blood loss in the LTG group was less than that in the OTG group. No cases in the LTG group required open conversion. Postoperatively, the first meal and defecation were earlier in the LTG group than in the OTG group. The overall survival rates of the two groups were comparable. Laparoscopic total gastrectomy is a feasible surgical option for RGC.

Sections du résumé

BACKGROUND/AIM OBJECTIVE
The safety and efficacy of laparoscopic total gastrectomy (LTG) for remnant gastric cancer (RGC) remains unclear. The purpose of this study was to compare the clinical outcomes of LTG with open total gastrectomy (OTG) for RGC.
PATIENTS AND METHODS METHODS
Twenty-two patients who underwent total gastrectomy for RGC were enrolled in this study.
RESULTS RESULTS
LTG was carried out in seven patients, and OTG was performed in the remaining 15 patients. The mean operation time in the LTG group was longer than that in the OTG group. The estimated blood loss in the LTG group was less than that in the OTG group. No cases in the LTG group required open conversion. Postoperatively, the first meal and defecation were earlier in the LTG group than in the OTG group. The overall survival rates of the two groups were comparable.
CONCLUSION CONCLUSIONS
Laparoscopic total gastrectomy is a feasible surgical option for RGC.

Identifiants

pubmed: 32606171
pii: 34/4/1987
doi: 10.21873/invivo.11996
pmc: PMC7439895
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1987-1992

Informations de copyright

Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Références

Gastric Cancer. 2015 Jan;18(1):177-82
pubmed: 24477417
Br J Surg. 1995 Nov;82(11):1540-3
pubmed: 8535813
Br J Surg. 2007 Jan;94(1):92-5
pubmed: 17054314
Hepatogastroenterology. 2003 Mar-Apr;50(50):587-91
pubmed: 12749279
Anticancer Res. 2016 Apr;36(4):1999-2003
pubmed: 27069193
Int J Clin Exp Med. 2015 Nov 15;8(11):21152-8
pubmed: 26885048
Surg Endosc. 2020 Feb;34(2):847-852
pubmed: 31139994
Ann Gastroenterol Surg. 2018 Nov 03;3(2):181-186
pubmed: 30923787
Surg Endosc. 2014 Jan;28(1):289-96
pubmed: 24013469
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Surg Endosc. 2014 Aug;28(8):2452-8
pubmed: 24622766
Surg Case Rep. 2019 Apr 17;5(1):63
pubmed: 31001749
J Am Coll Surg. 1996 Jan;182(1):1-6
pubmed: 8542082
Surg Laparosc Endosc Percutan Tech. 2008 Oct;18(5):502-5
pubmed: 18936676
Surg Endosc. 2010 Dec;24(12):3205-9
pubmed: 20490555
Asian J Endosc Surg. 2019 Jan;12(1):58-63
pubmed: 29745474
Gastric Cancer. 2017 Jan;20(1):1-19
pubmed: 27342689
Gastric Cancer. 2011 Jun;14(2):101-12
pubmed: 21573743
Ann Surg Treat Res. 2016 Feb;90(2):106-10
pubmed: 26878019
World J Surg Oncol. 2014 Nov 13;12:342
pubmed: 25392032
Anticancer Res. 2015 Sep;35(9):5023-6
pubmed: 26254402
Hepatogastroenterology. 2015 May;62(139):752-7
pubmed: 26897967
Int J Surg. 2016 Oct;34:17-22
pubmed: 27543820
World J Surg. 2008 Jul;32(7):1466-72
pubmed: 18340481
In Vivo. 2018 Nov-Dec;32(6):1513-1518
pubmed: 30348710
World J Surg. 2018 Mar;42(3):782-787
pubmed: 28924721
Surg Laparosc Endosc Percutan Tech. 2005 Aug;15(4):226-9
pubmed: 16082311
Gut. 1998 Sep;43(3):342-4
pubmed: 9863478
Surg Today. 2014 Feb;44(2):271-6
pubmed: 23463536
Langenbecks Arch Surg. 2013 Feb;398(2):341-5
pubmed: 22777535
Surg Today. 2017 Oct;47(10):1274-1281
pubmed: 28321575
J Gastric Cancer. 2015 Dec;15(4):286-9
pubmed: 26819808
Surg Laparosc Endosc Percutan Tech. 2009 Apr;19(2):e57-60
pubmed: 19390266

Auteurs

Mitsuhiko Ota (M)

Department of Gastrointestinal Surgery, National Hospital Organization, Kyushu Cancer Center, Fukuoka, Japan ota.mitsuhiko.ua@mail.hosp.go.jp.

Masahiko Ikebe (M)

Department of Gastrointestinal Surgery, National Hospital Organization, Kyushu Cancer Center, Fukuoka, Japan.

Yuki Shin (Y)

Department of Gastrointestinal Surgery, National Hospital Organization, Kyushu Cancer Center, Fukuoka, Japan.

Masaki Kagawa (M)

Department of Gastrointestinal Surgery, National Hospital Organization, Kyushu Cancer Center, Fukuoka, Japan.

Yohei Mano (Y)

Department of Hepatobiliary-Pancreatic Surgery, National Hospital Organization, Kyushu Cancer Center, Fukuoka, Japan.

Tomonori Nakanoko (T)

Department of Gastrointestinal Surgery, National Hospital Organization, Kyushu Cancer Center, Fukuoka, Japan.

Yuichiro Nakashima (Y)

Department of Gastrointestinal Surgery, National Hospital Organization, Kyushu Cancer Center, Fukuoka, Japan.

Hideo Uehara (H)

Department of Gastrointestinal Surgery, National Hospital Organization, Kyushu Cancer Center, Fukuoka, Japan.

Masahiko Sugiyama (M)

Department of Gastrointestinal Surgery, National Hospital Organization, Kyushu Cancer Center, Fukuoka, Japan.

Tomohiro Iguchi (T)

Department of Hepatobiliary-Pancreatic Surgery, National Hospital Organization, Kyushu Cancer Center, Fukuoka, Japan.

Keishi Sugimachi (K)

Department of Hepatobiliary-Pancreatic Surgery, National Hospital Organization, Kyushu Cancer Center, Fukuoka, Japan.

Manabu Yamamoto (M)

Department of Surgery, Fukuoka Sanno Hospital, Fukuoka, Japan.

Masaru Morita (M)

Department of Gastrointestinal Surgery, National Hospital Organization, Kyushu Cancer Center, Fukuoka, Japan.

Yasushi Toh (Y)

Department of Gastrointestinal Surgery, National Hospital Organization, Kyushu Cancer Center, Fukuoka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH